MAD2L2 dimerization and TRIP13 control shieldin activity in DNA repair.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
14 09 2021
Historique:
received: 04 02 2021
accepted: 28 08 2021
entrez: 15 9 2021
pubmed: 16 9 2021
medline: 13 10 2021
Statut: epublish

Résumé

MAD2L2 (REV7) plays an important role in DNA double-strand break repair. As a member of the shieldin complex, consisting of MAD2L2, SHLD1, SHLD2 and SHLD3, it controls DNA repair pathway choice by counteracting DNA end-resection. Here we investigated the requirements for shieldin complex assembly and activity. Besides a dimerization-surface, HORMA-domain protein MAD2L2 has the extraordinary ability to wrap its C-terminus around SHLD3, likely creating a very stable complex. We show that appropriate function of MAD2L2 within shieldin requires its dimerization, mediated by SHLD2 and accelerating MAD2L2-SHLD3 interaction. Dimerization-defective MAD2L2 impairs shieldin assembly and fails to promote NHEJ. Moreover, MAD2L2 dimerization, along with the presence of SHLD3, allows shieldin to interact with the TRIP13 ATPase, known to drive topological switches in HORMA-domain proteins. We find that appropriate levels of TRIP13 are important for proper shieldin (dis)assembly and activity in DNA repair. Together our data provide important insights in the dependencies for shieldin activity.

Identifiants

pubmed: 34521823
doi: 10.1038/s41467-021-25724-y
pii: 10.1038/s41467-021-25724-y
pmc: PMC8440562
doi:

Substances chimiques

Cell Cycle Proteins 0
DNA-Binding Proteins 0
MAD2L2 protein, human 0
Mad2 Proteins 0
Phthalazines 0
Piperazines 0
Recombinant Proteins 0
SHLD1 protein, human 0
SHLD2 protein, human 0
SHLD3 protein, human 0
DNA 9007-49-2
ATPases Associated with Diverse Cellular Activities EC 3.6.4.-
TRIP13 protein, human EC 3.6.4.-
Cisplatin Q20Q21Q62J
olaparib WOH1JD9AR8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5421

Informations de copyright

© 2021. The Author(s).

Références

Nucleic Acids Res. 2020 Jun 4;48(10):5485-5498
pubmed: 32347940
Methods Mol Biol. 2012;920:379-91
pubmed: 22941618
Proc Natl Acad Sci U S A. 2018 Aug 28;115(35):E8191-E8200
pubmed: 30111544
Chromosoma. 2015 Sep;124(3):333-9
pubmed: 25895724
J Exp Med. 2010 Feb 15;207(2):417-27
pubmed: 20142431
Nature. 2007 Sep 27;449(7161):478-82
pubmed: 17713479
Nature. 2015 May 28;521(7553):537-540
pubmed: 25799990
Proc Natl Acad Sci U S A. 2020 Oct 27;117(43):26795-26803
pubmed: 33051298
EMBO Rep. 2019 May;20(5):
pubmed: 30948458
Nat Commun. 2018 Sep 25;9(1):3925
pubmed: 30254264
Nat Struct Mol Biol. 2020 Oct;27(10):913-924
pubmed: 32807989
Nature. 2015 May 28;521(7553):541-544
pubmed: 25799992
Nucleic Acids Res. 2018 Apr 6;46(6):2945-2955
pubmed: 29447381
Nat Commun. 2016 Feb 02;7:10529
pubmed: 26833222
Nat Struct Mol Biol. 2013 Mar;20(3):317-25
pubmed: 23377543
EMBO J. 2018 Sep 14;37(18):
pubmed: 30154076
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Dec 1;65(Pt 12):1302-5
pubmed: 20054135
EMBO J. 2017 Aug 15;36(16):2419-2434
pubmed: 28659378
J Biol Chem. 2020 Jan 3;295(1):250-262
pubmed: 31796627
Nature. 2018 Jul;559(7713):285-289
pubmed: 29973717
Cell Rep. 2016 Feb 9;14(5):1086-1099
pubmed: 26832417
Nature. 2018 Aug;560(7716):112-116
pubmed: 30022158
Nature. 2018 Aug;560(7716):122-127
pubmed: 30046110
Genes Dev. 2008 May 1;22(9):1221-30
pubmed: 18451109
Cell. 2018 May 3;173(4):972-988.e23
pubmed: 29656893
J Biol Chem. 2010 Apr 16;285(16):12299-307
pubmed: 20164194
Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11536-40
pubmed: 26324890
Elife. 2015 Apr 28;4:
pubmed: 25918846
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Nature. 2017 Feb 23;542(7642):498-502
pubmed: 28102834
J Biol Chem. 2017 Oct 27;292(43):17658-17667
pubmed: 28887307
Dev Cell. 2009 Jan;16(1):105-17
pubmed: 19154722
Nucleic Acids Res. 2015 Jan;43(2):1000-11
pubmed: 25567983
Proc Natl Acad Sci U S A. 2016 May 10;113(19):E2564-9
pubmed: 27114506
EMBO J. 2018 Jun 15;37(12):
pubmed: 29789392
J Mol Biol. 1990 May 20;213(2):221-2
pubmed: 2342105
J Cell Biol. 2015 Nov 23;211(4):745-55
pubmed: 26598612
Nature. 2019 Nov;575(7782):385-389
pubmed: 31666703
PLoS Biol. 2009 Jan 13;7(1):e10
pubmed: 19143472
Nat Struct Mol Biol. 2004 Apr;11(4):338-45
pubmed: 15024386
Genes Cells. 2010 Mar;15(3):281-96
pubmed: 20088965
PLoS One. 2009 Sep 15;4(9):e7020
pubmed: 19753112
Nat Commun. 2020 Apr 24;11(1):1972
pubmed: 32332881
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
J Biol Chem. 2019 Oct 25;294(43):15733-15742
pubmed: 31484720
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12019-24
pubmed: 25092294
Nat Cell Biol. 2020 Jan;22(1):87-96
pubmed: 31915374
Nat Cell Biol. 2018 Aug;20(8):954-965
pubmed: 30022119
Curr Biol. 2015 Oct 19;25(20):R1002-18
pubmed: 26485365
Nature. 2018 Aug;560(7716):117-121
pubmed: 30022168
J Cell Biol. 2013 Oct 14;203(1):87-100
pubmed: 24100295
Nat Cell Biol. 2011 Aug 21;13(9):1139-45
pubmed: 21857671
Nucleic Acids Res. 2019 Sep 19;47(16):8348-8361
pubmed: 31410467
Nat Commun. 2014 Jul 31;5:4527
pubmed: 25078033
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Nat Struct Mol Biol. 2014 Apr;21(4):366-74
pubmed: 24658350
Int Immunol. 1996 Feb;8(2):193-201
pubmed: 8671604
Nucleic Acids Res. 2014 Feb;42(3):e19
pubmed: 24362840
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
Nature. 2018 Jul;559(7713):274-278
pubmed: 29973720

Auteurs

Inge de Krijger (I)

Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Bastian Föhr (B)

Laboratory of Signal Dynamics, Max-Planck Institute for Biophysical Chemistry, Göttingen, Germany.

Santiago Hernández Pérez (SH)

Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Estelle Vincendeau (E)

Genome Integrity, Immunity and Cancer Unit, Equipe Labellisée Ligue Contre Le Cancer, INSERM U1223, Institut Pasteur, Paris, France.
Université de Paris, Sorbonne Paris Cité, Paris, France.

Judit Serrat (J)

Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Alexander Marc Thouin (AM)

Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Vivek Susvirkar (V)

Laboratory of Signal Dynamics, Max-Planck Institute for Biophysical Chemistry, Göttingen, Germany.

Chloé Lescale (C)

Genome Integrity, Immunity and Cancer Unit, Equipe Labellisée Ligue Contre Le Cancer, INSERM U1223, Institut Pasteur, Paris, France.

Inés Paniagua (I)

Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Liesbeth Hoekman (L)

Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Simranjeet Kaur (S)

Laboratory of Signal Dynamics, Max-Planck Institute for Biophysical Chemistry, Göttingen, Germany.

Maarten Altelaar (M)

Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands.

Ludovic Deriano (L)

Genome Integrity, Immunity and Cancer Unit, Equipe Labellisée Ligue Contre Le Cancer, INSERM U1223, Institut Pasteur, Paris, France.

Alex C Faesen (AC)

Laboratory of Signal Dynamics, Max-Planck Institute for Biophysical Chemistry, Göttingen, Germany.

Jacqueline J L Jacobs (JJL)

Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. j.jacobs@nki.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH